Background/Objectives: To assess the association between moderate N-terminal natriuretic peptide (NT-proBNP) and cardiac alterations and prognosis in septuagenarians without heart failure (HF). Methods: From the STROKESTOP II screening study, 230 individuals aged 75/76 years with NT-proBNP < 900 ng/L were randomly selected. Subjects with persistent atrial fibrillation (AF), more than mild valvular disease, or HF were excluded. Echocardiography was performed. NT-proBNP ≥ 125 ng/L and paroxysmal AF (pAF) on thumb ECG were used as grouping variables. Participants were followed up during a median of 5 years for cardiovascular mortality, HF, AF, and cerebrovascular events. Cox regression analysis was employed for prognostic assessment. Results: Three groups were identified: SR ≥ 125 (n = 94, no pAF and NT-proBNP ≥ 125 ng/L), pAF (n = 77, pAF and NT-proBNP ≥ 125 ng/L), and controls (n = 30, no pAF and NT-proBNP < 125 ng/L). NT-proBNP was not associated with structural (left atrial volume and left ventricular (LV) mass) or functional (E/e’, LV strain) alterations in any group (p > 0.05). Cardiovascular risk factors (HR: 4.6; CI = 1.7–12.3; p = 0.002), but not NT-proBNP (HR: 1.9; CI = 0.7–5.1; p = 0.2), entailed a prognostic value for the composite endpoint of HF, AF, and cardiovascular death. Conclusions: In septuagenarians without HF, modest NT-proBNP elevation was not associated with echocardiographic changes or prognosis
5 November 2025 in Clinical Physiology and Functional Imaging
Aim: To investigate left atrial (LA) function assessed by peak atrial longitudinal strain (PALS) in an elderly population with silent paroxysmal atrial fibrillation (PAF) compared to age‐matched control group. Methods: From the STROKESTOP2‐study, patients with newly diagnosed silent PAF were enrolled together in a randomly selected age‐matched control group. All patients had NT‐proBNP levels between 125 and 900 ng/L. Echocardiographic examinations were performed and analyzed offline using dedicated software. In addition to conventional echocardiographic variables, PALS was measured using a two‐dimensional speckle tracking (2D‐ST) biplane. Results: The study population (mean age 76 ± 0.3) demonstrated significantly reduced PALS in patients with PAF ( N = 69) compared to controls ( N = 94) (23.9% ± 6.5% vs 30.7% ± 7.6%, p < 0.001). In the PAF group, 29 (42%) patients had normal LA volume index (LAVI) defined as 34 mL/m 2 . When subgroups with normal LAVI were compared, PALS was reduced in PAF compared to controls (25.1 ± 8.0 vs 31.1 ± 7.8, p = 0.001). NT‐proBNP levels did not differ between the PAF group (median 228 ng/L) and the control group (median: 217 ng/L) ( p = 0.16). In multiple linear regression analysis, left ventricular global longitudinal strain, stroke volume index and LAVI were independent predictors of PALS. Receiver operating characteristic curve identified PALS threshold <22% for predicting risk of silent PAF. Conclusion: PALS was significantly reduced in PAF patients even in the absence of significant LA remodeling. PALS <22% predicts risk for silent PAF in general elderly population. In high‐risk patients PALS could be used for AF screening enrichment.
Purpose: To study left atrial stiffness index (LASI) and left atrial activation time (LA-AT) changes in an older population with silent paroxysmal atrial fibrillation (PAF) compared to age-matched control. Methods: Individuals with newly diagnosed PAF and a randomly selected age-matched control group without AF were enrolled from STROKESTOP2-study. All participants had NT-proBNP levels 125–900 ng/L. TTE examinations were analyzed retrospectively offline using dedicated software. Besides conventional echocardiographic measurements, LA-AT was obtained by measuring the time delay between the onset of the P-wave on ECG and tissue Doppler Á peak wave in lateral LA wall. LASI was calculated as the ratio of left ventricular filling (E/é) to peak atrial longitudinal strain (PALS). Results: Mean age was 76 ± 0.3 years. The PAF group ( n = 67) presented significant increase of LASI (0.41 (0.29–0.60) vs. 0.32 (0.29–0.43), P = 0.001) and prolonged LA-AT (170 (140–180) ms vs. 140 (120–144) ms, P < 0.001) compared to controls ( n = 94). Subgroup analysis in participants with normal LA volume index (LAVI) ≤ 34 ml/m 2 , LASI and LA-AT remained significantly increased/prolonged in PAF ( N = 27) compared to controls ( N = 72). NT-proBNP-levels did not differ between PAF (228 (181–348) ng/L) and controls (216 (156–317) ng/L) ( P = 0.18). ROC curve analysis identified thresholds LASI > 0.54 and LA-AT > 139 msec for discrimination of silent PAF. Conclusion: Indices reflecting LA stiffness and atrial conduction delay were significantly elevated in recently diagnosed PAF patients. LASI and LA-AT thresholds might non-invasively detect early atrial remodeling without structural enlargement in elderly patients with high risk of PAF and mildly increased NT-proBNP levels.
Purpose: To study left atrial stiffness index (LASI) and left atrial activation time (LA-AT) changes in an older population with silent paroxysmal atrial fibrillation (PAF) compared to age-matched control. Methods: Individuals with newly diagnosed PAF and a randomly selected age-matched control group without AF were enrolled from STROKESTOP2-study. All participants had NT-proBNP levels 125-900 ng/L. TTE examinations were analyzed retrospectively offline using dedicated software. Besides conventional echocardiographic measurements, LA-AT was obtained by measuring the time delay between the onset of the P-wave on ECG and tissue Doppler Á peak wave in lateral LA wall. LASI was calculated as the ratio of left ventricular filling (E/é) to peak atrial longitudinal strain (PALS) Results: Mean age was 76±0.3. The PAF group (n=67) presented significant increase of LASI (0.41 (0.29 – 0.60) vs. 0.32 (0.29 – 0.43), P=0.001) and prolonged LA-AT (170 (140 – 180) ms vs. 140 (120 – 144) ms, P0.33 and LA-AT>139 msec for predicting silent PAF. Conclusions: Indices reflecting LA stiffness and fibrosis were significantly elevated in recently diagnosed PAF patients and elevated in the absence of LA dilatation. LASI and LA-AT thresholds might non-invasively provide additional information in patients with high risk of PAF in general elderly population.